The Research Group for the study in the Modulation of the AhR Pathway is composed by basic and clinical researchers of the Universitat de València and the La Fe University and Polytechnic Hospital. Our purpose is to explain the role of the pathway of the receptor of aromatic hydrocarbons (AhR) in physiological and physio pathological conditions such as cancer, diabetic retinopathy, neonatal sepsis, necrotising enter colitis and vascular disorders, among others. This could also open up lines of research focused on treating alterations in the AhR pathway and identifying new therapeutic targets. Additionally, we focus on the search of endogenous or exogenous ligands, as well as those derived from the microbiota of the metabolism, which could turn out to be better capable of modulating the AhR pathway to improve the physio pathological conditions.